The overwhelming majority of GlaxoSmithKline shareholders on Thursday approved the proposed transaction with Novartis.
Branded Pharmacy News
The Food and Drug Administration on Wednesday approved Xtoro (finafloxacin otic suspension), a new drug that's used to treat acute otitis externa, commonly known as swimmer's ear.
To date, the Food and Drug Administration's Center for Drug Evaluation and Research has approved 35 novel new drugs in 2014, compared to 27 in 2013.
The flu continues to pick up in pockets of the Midwest and across the South, according to the latest Walgreens Flu Index report, a weekly report developed to provide state- and market-specific information regarding flu activity.
Use of cigarettes, alcohol and abuse of prescription pain relievers among teens has declined since 2013, while marijuana use rates were stable, according to the 2014 Monitoring the Future survey, released Tuesday.
Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use.
Sanofi Pasteur announced that the FDA approved the supplemental biologics license application for Fluzone Intradermal Quadrivalent vaccine.
The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.
The Department of Health and Human Services on Tuesday awarded $36.3 million in Affordable Care Act funding to 1,113 health centers in all 50 states, the District of Columbia and seven U.S. Territories.
Flu activity is picking up across the South, according to the latest Walgreens Flu Index.